Julphar Gulf Pharmaceutical Industries announced today the appointment of the company’s Associate Director of Finance, Laurent de Chazeaux, as Acting Chief Financial Officer, effective immediately. Laurent replaces Jerome Carle, who has been appointed General Manager of Julphar.

Commenting on the appointment of de Chazeaux as Acting CFO, Julphar’s Chairman, Sheikh Faisal Bin Saqr Al Qasimi, said, "Laurent is an established financial executive with extensive background overseeing finance organisations. With him leading the finance team, I am confident that we will be well-positioned to enter the next phase of our strategy execution."

"I am much honoured to have been appointed to this role," said Laurent de Chazeaux. "I will work closely with the executive team and focus on driving performance to help the company achieve its next stages of growth."

As Acting CFO of Julphar, de Chazeaux will be responsible for leading Julphar’s finance department and keeping accurate financial records. He will be in charge of the administrative and risk management operations and will develop financial strategies in line with the company’s objectives. He will report to the company’s recently appointed General Manager, Jerome Carle.

Over the last 20 years, de Chazeaux has worked in a number of senior finance roles in the pharmaceutical industry and investment banking. He spent several years working for Cowen, where he was in charge of analysing performances of midsize European pharmaceutical companies, and before joining Julphar as Associate Director Finance in June 2017, he worked at Sanofi and as Finance Director at AstraZeneca. Laurent has a degree from EDHEC Business School (France) in International Management and has been living in the Middle East for the past 10 years.

Established in 1980, Julphar is one of the largest pharmaceutical manufacturers in Middle East and North Africa, producing over 200 branded products across 16 facilities.